Table 3 Post endoscopy outcomes of the studied groups
Variables | Sclerotherapy group N: 56 (%) | Cyanoacrylate group N: 57 (%) | P-value |
|---|---|---|---|
Control of active bleeding | 47 (83.93%) | 56 (98.25%) | 0.007* |
Rebleeding | 15 (26.79%) | 11 (19.30%) | 0.344 |
Complications: | |||
Retrosternal pain | 12 (21.43%) | 6 (10.53%) | 0.113 |
Dysphagia | 9 (16.07%) | 4 (7.02%) | 0.132 |
Fever | 4 (7.14%) | 4 (7.02%) | 0.979 |
SBP | 3 (5.36%) | 2 (3.51%) | 0.633 |
Hospital stay (days) | 0.067 | ||
Range | (2–17) | (2–13) | |
Mean ± SD | 4.79 ± 2.85 | 3.95 ± 1.88 | |
Mortality | 11 (19.64%) | 9 (15.79%) | 0.592 |